European utilization of the implantable defibrillator: Has 10 years changed the enigma?

Europace

Volumn 12, Issue 8, 2010, Pages 1063-1069

  John Camm, A ^a   Nisam, Seah ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b Boston Scientific Corporation   (Belgium)

Author keywords

Cost effectiveness; ESC guidelines; Implantable cardioverter defibrillator (ICD); Primary prevention; Sudden death

Indexed keywords

CATHETER ABLATION; CLINICAL ASSESSMENT; CONTINUING EDUCATION; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; FINANCIAL MANAGEMENT; FRANCE; GERMANY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; ITALY; MEDICAL AUDIT; PATIENT REFERRAL; PRIORITY JOURNAL; REVIEW; SCREENING; TREATMENT INDICATION; UNITED KINGDOM;

ARRHYTHMIAS, CARDIAC; COST-BENEFIT ANALYSIS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EUROPE; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 77955218647     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq282     Document Type: Review

References (31)

1. Centers for Disease Control and Prevention. State-Specific Mortality from Sudden Cardiac Death\United States 1999. Morb Mortal Wkly Rep (MMWR) 2002;51:123-126
2. European data from European Registries Book. European Society of Cardiology 1999; US data from 1999 AHA Heart and Stroke Statistics Update.
3. US Census Bureau, Statistical Abstract of the United States: 2001.
4. American Cancer Society, Inc., Surveillance Research, Cancer Facts and Figures 2001.
5. 2002 Heart and Stroke Statistical Update, American Heart Association.
6. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrilla-tor in human beings. N Engl J Med 1980;303:322-324
7. Camm AJ, Nisam S. The utilization of the implantable defibrillator\a European Enigma. Eur Heart J 2000;21:1998-2004.
8. Zipes DP, Camm AJ, Borggrefe M, Buxton A, Chairman B, Fromer M et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 2006;27:2099-2140 (Pubitemid 44418943)
9. Epstein A, DiMarco J, Ellenbogen K, Estes M, Freedman R, Gettes L et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2008;117: e350-408.
10. Vardas P (Chairperson), Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H et al. Guidelines for cardiac pacing and cardiac resynchronization therapy. Euro-pace 2007;9:959-998
11. Task Force for Diagnosis, Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, Dickstein K (Chairman), Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA et al. ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-442. www.eucomed.org. EUCOMED data 2005-2007. September 2008. Last accessed 23 March 2010.
12. Plummer C, Irving J, McComb J. The incidence of implantable cardioverter defibrillator indications in patients admitted to all coronary care units in a single district. Europace 2005;7:266-272
13. Borleffs C, Wilde A, Cramer J, Wever E, Mosterd A. Clinical implementation of guidelines for cardioverter defibrillation implantation: lost in translation? Neth Heart J 2007;15:129-132
14. Ruskin J, Camm AJ, Zipes D, Hallstrom A, Mcgrory-Usset M. Implantable cardio-verter defibrillation utilization based on discharge diagnoses from Medicare and managed care patients. J Cardiovasc Electrophsiol 2002;13:38-43.
15. Hernandez AF, Fonarow GC, Liang L, Al-Khatib SM, Curtis LH, LaBresh KA et al. Sex and racial differences in the use of implantable cardioverter- defibrillators among patients hospitalized with heart failure. JAMA 2007;298:1525-1532
16. Guidant UK Ltd (B. Kershaw), based on analysis commissioned to the York Health Economics Commission. York, UK (P. West, Director).
17. Credit Suisse Equity Research. First Boston\Section Overview, Medical supplies and devices\8 June 2005.
18. Merrill Lynch Medical technology industry overview: Cardiovascular MedTech\A preferred sub-sector. 20 November 2007.
19. European Registries Book, European Society of Cardiology, 1999.
20. American Heart Association Heart and Stroke Statistics Update, 1999.
21. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2001;22:1374-1450
22. Birnie D, Rea T, Stiel I, Tang A, Rho R, Page R et al. ICD placement after cardiac arrest in the U.S. and Canada: contrasting clinical practice with expert opinion. Heart Rhythm 2008;5:S78 (Abstract).
23. Boston Scientific. HF-Radar, Screening for Heart Failure patients, www.hf-radar. com/www.cardiocircle.com, Date of consultation: June 2008.
24. Vester E, Stellbrink C, de Haan F, for the CRediT investigators. Low penetration of device therapy in CRT/ICD indicated patients and long term outcome. Results from the CRediT heart failure registry. Eur Heart J 2008;29:816.
25. EUCOMED Awareness of device therapy survey, Brussels, December, 2006.
26. Quan KJ, Amit G, Costantini O. Awareness of referral criteria for implantable defibrillator implantation amongst primary care physicians. Heart Rhythm 2008; 5: (Abstract AB 22-6).
27. Saunders G, Hlatky M, Owens D. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 2005;353:1471-1480
28. Greenberg S, Epstein A, Deering T, Goldman D, Ghidina M, Neason C et al. A Comparison of ICD Implantations in the United States Versus Italy. PACE 2007; 30:S143-6.
29. Institute national d'assurance maladie-invalidité (INAM I) official statistics, November, 2007.
30. Stein K, Mittal S, Gilliam R, Gilligan DM, Meyer TE. Event rates are similar in patients receiving ICDs for primary and secondary prevention indications. Heart Rhythm 2007;4:S215 (Abstract).
31. Santini M, Russo M, Botto G, Lunati M, Proclemer A, Schmidt B et al. Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients